News

Switching to Humira biosimilars saved Navitus clients more than $315 million in upfront costs in 2024 and resulted in a 60% ...
In an interview, James D. Chambers, Ph.D., from Tufts Medical Center, talks about the factors that are impacting the ...
EMA advisors at the Committee for Medicinal Products for Human Use (CHMP) recommended Sandoz’s adalimumab Humira biosimilar under three brand names – Halimatoz, Hefiya and Hyrimoz. The firm ...
This week has seen the launch of new and lower-priced biosimilars to AbbVie’s Humira (adalimumab), many months after Amgen’s Amjevita (adalimumab-atto) was released in the US in January.
All SDRs and shares allocated have now been delivered to the counterparties, with a transfer of 7.5 million treasury shares ...
possible malignancies and COPD exacerbation Adalimumab (Humira®) Injection site reactions and upper respiratory tract infections Serious bacterial infections, unusual infections (tuberculosis and ...
New research highlights the efficacy and high patient satisfaction of adalimumab biosimilars in treating inflammatory ...
The best time to take melatonin is 30 minutes to one hour before your desired bedtime. Learn more about the best time to take ...
Patients with inflammatory bowel disease (IBD) show high acceptance of adalimumab biosimilars, achieving positive outcomes and clinical remission after switching.
The Food and Drug Administration has designated Hadlima (adalimumab-bwwd) an interchangeable biosimilar to Humira (adalimumab).